Article
Frequent and specific mutations of the rat p53 gene in hepatocarcinomas induced by tamoxifen.
Cancer research - 15 Jul 1994
Vancutsem P M, Lazarus P, Williams G M
Abstract excerpt
Tamoxifen (TAM) is a triphenylethylene antiestrogen used for the treatment, and in clinical trials for the prevention, of breast cancer in women. In rats, TAM is a strong liver carcinogen which induces the formation of liver DNA adducts. The DNA of 24 hepatocarcinomas (HCCs) collected at necropsy from individual female Sprague-Dawley rats that were given 22.6 mg/kg TAM daily for 12 months was studied for the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
